Medtronic Gains FDA Approval for Hugo Robotic Surgical System
Medtronic received FDA approval for its Hugo robotic-assisted surgery platform to perform urologic procedures, marking a significant step into the market dominated by Intuitive Surgical. The company now aims to compete in an industry projected to grow from $13.8 billion last year to $63.7 billion by 2035.
Topics: market competition medical technology robotic surgery